Max Healthcare gains on broker upgrade

18 Feb 2025

Max Healthcare gains on broker upgrade

The broker revised its rating on the healthcare chain from Neutral to Buy and increased the target price to Rs 1,200.

The brokerage's optimistic outlook is based on Max Healthcare's robust earnings growth potential, underpinned by strong fundamentals. According to the report, the company's ambitious plan to double its bed capacity within the next three years is a key driver for future growth. The company's asset-light model distinguishes it as a leader in the healthcare sector, allowing for efficient expansion and profitability, it added.

Max Healthcare Institute is one of India's largest healthcare organizations. It operates 22 healthcare facilities (5,000+ beds) with a significant presence in North India.

On a consolidated basis, net profit of Max Healthcare Institute declined 17.47% to Rs 238.80 crore while net sales rose 39.95% to Rs 1868.31 crore in Q3 December 2024 over Q3 December 2023.

The company reported an exceptional loss of Rs 73.63 crore in Q3 December 2024 stemming from charges paid to Yamuna Expressway Industrial Development Authority (YEIDA) for seeking permission for change in shareholding of Jaypee Healthcare.

Top Blogs

blog-article-image-one

Share Market

Low Price Shares

0 mins read . Dec 18, 2024

blog-article-image-one

Share Market

Nifty 50 Top 10 Stocks

0 mins read . Dec 18, 2024

blog-article-image-one

Share Market

Best Stocks in 2025

0 mins read . Dec 18, 2024

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions